Remogliflozin Etabonate + Vildagliptin

Uses

How Remogliflozin Etabonate and Vildagliptin Work Remogliflozin Etabonate and Vildagliptin is a combination of two anti-diabetic medications: Remogliflozin Etabonate and Vildagliptin. Remogliflozin Etabonate functions by eliminating excess sugar from the body through urine. Vildagliptin enhances the release of insulin from the pancreas and decreases the hormones that elevate blood sugar levels. This combination effectively reduces both fasting and post-meal sugar levels.

How it Works

Common side effects of Remogliflozin Etabonate and Vildagliptin include diarrhea, nausea, headache, hypoglycemia (low blood glucose level), tremors, dizziness, weight gain, urinary tract infection, fever, cough, ketonuria, constipation, dyslipidemia, and hypotension (low blood pressure).

Other Combinations